4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1828 | N-Acetyl-Ser-Asp-Lys-Pro | RAAS | |
Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin β4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethalit... | |||
TP1371 | N-Acetyl-Ser-Asp-Lys-Pro TFA | ||
N-Acetyl-Ser-Asp-Lys-Pro (TFA) is an endogenous tetrapeptide that is naturally produced in the bone marrow. It serves as a specific substrate for the N-terminal site of ACE, the enzyme responsible for angiotensin convert... | |||
T75752 | N-Acetyl-Ser-Asp-Lys-Pro acetate | ||
N-Acetyl-Ser-Asp-Lys-Pro (Ac-SDKP) acetate, a specific substrate for the N-terminal active site of angiotensin-converting enzyme (ACE), functions as a natural inhibitor of pluripotent hematopoietic stem cell proliferatio... | |||
T28632 | RXP-407 | RXP407 | |
RXP 407 is a selective inhibitor of the N-domain of angiotensin I-converting enzyme. RXP 407 blocks the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis in vivo. |